长托宁和阿托品作为慢性阻塞性肺疾病患者麻醉前用药的效果分析.docVIP

精品论文 参考文献 长托宁和阿托品作为慢性阻塞性肺疾病患者麻醉前用药的效果分析 廖余红 　　湖南省郴州市柿竹园医院 综合住院部 423037 　　摘要：目的：了解慢性阻塞性肺疾病患者麻醉前选用长托宁和阿托品药物的临床效果和差异性。方法：随机抽取本院近年来收治手术治疗的合并慢性阻塞性肺疾病外科治疗患者100例，根据麻醉前药物选择不同将其分为A组与B组，A组患者麻醉前药物选用阿托品，B组患者麻醉前药物选用长托宁，每组均有患者50名。对比2组患者给药前后各时间段的生理功能、BIS数值变化及麻醉恢复情况。结果：2组患者各时间段血压、心率和腺体分泌对比中，血压比较无显著差异性，无统计学意义（P＞0.05）；B组患者心率和腺体分泌生理功能相对于A组患者有显著优越性，差异有统计学意义（P＜0.05）；相对B患者，A患者意识消失时间明显延长；A组患者相对B组深呼吸次数明显增多；B组患者BIS数值在插管的时候出现变化程度较小，差异有统计学意义（P＜0.05）；B组患者各项麻醉恢复情况诸如睁眼时间、拔管时间和呼吸满意时间等相对于A组患者均有显著优越性，差异有统计学意义（P＜0.05）。结论：对慢性阻塞性肺疾病患者麻醉前肌肉注射长托宁能够取得令人满意的术后麻醉恢复效果，且不会对老年患者各项指标造成严重影响，缓解患者痛苦以及提高其生活质量，值得临床推广。 　　关键词：长托宁；阿托品；慢性阻塞性肺疾病 　　[Abstract]Objective：to understand the clinical effect and selection of penehyclidine hydrochloride and atropine differences in drug anesthesia in patients with chronic obstructive pulmonary disease before.Methods：randomly selected 100 patients treated in our hospital in recent years with chronic obstructive pulmonary disease surgical treatment for surgical treatment of patients，according to the pre anesthesia medication different choices will be divided into group A and group B，before anesthesia drug using atropine group A patients，drug selection before long carrier Ning anesthesia in patients with B group，each group had 50 patients name.The 2 groups were compared before and after administration of physiological functions，each time the BIS value change and anesthesia recovery.Results：the 2 groups of patients with blood pressure，heart rate and the time of glandular secretion in contrast，no significant difference in blood pressure，no statistical significance（P gt; 0.05）；group B patients with heart rate and gland secretion of physiological function with respect to the patients in group A had a significant superiority，the difference was statistically significant（P lt; 0.05）relative to B patients；patients lost consciousness，the A was prolonged；the patients in the A group relative to the B group deep breathing significantly increased the number of patients in the B group；numerical